Skip to Content

Bionoid Pharma Inc Ordinary Shares BINP

Morningstar Rating
$0.34 −0.10 (22.37%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BINP is trading at a 547% premium.
Price
$0.34
Fair Value
$5.68
Uncertainty
Extreme
1-Star Price
$4.85
5-Star Price
$2.36
Economic Moat
Zbbcy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BINP is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.44
Day Range
$0.200.35
52-Week Range
$0.061.04
Bid/Ask
$0.03 / $0.35
Market Cap
$18.36 Mil
Volume/Avg
76,101 / 35,441

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bionoid Pharma Inc is engaged in the production and sale of pain management and healthcare products. Through its subsidiary, the company provides Florella therapeutic magnet, a patented device to help alleviate the pain associated with menstrual cycles.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees
13

Valuation

Metric
BINP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BINP
Quick Ratio
0.14
Current Ratio
0.17
Interest Coverage
−527.14
Quick Ratio
No chart available

Profitability

Metric
BINP
Return on Assets (Normalized)
−1,430.83%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
SdzjvjcMcwnvv$183.1 Bil
Stryker Corp
SYK
CwxhjqvlqwZkqys$126.3 Bil
Boston Scientific Corp
BSX
QxvnccnmVjzbwkh$110.1 Bil
Medtronic PLC
MDT
PvlfklnvJxnfkw$100.9 Bil
Edwards Lifesciences Corp
EW
FdglftdqrpXftvkks$37.6 Bil
DexCom Inc
DXCM
QbhgsrdcsgZtjh$25.6 Bil
Koninklijke Philips NV ADR
PHG
RbxryqmgXdrdjkj$24.1 Bil
Steris PLC
STE
TdqyyfrrtRszkqnp$23.0 Bil
Zimmer Biomet Holdings Inc
ZBH
KyzbbmqlrsVcd$22.9 Bil
Align Technology Inc
ALGN
LthtfhwHcwlk$16.6 Bil

Sponsor Center